Status:
COMPLETED
Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences
Collaborating Sponsors:
Chinese Anti-Cancer Association
Conditions:
Breast Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
This study is to investigate sex hormones levels of Chinese patients with invasive breast cancer.The aim is to analyze biochemical monitoring results of premenopausal and postmenopausal patients to fa...
Detailed Description
Follicle stimulating hormone (FSH), estradiol (E2) and luteinizing hormone (LH) can serve as indicators in the determination of menopausal status. NCCN clinical practice guidelines for breast cancer r...
Eligibility Criteria
Inclusion
- Invasive breast cancer patients confirmed through pathology.
- For postmenopausal group: patients at the age ≥ 60 years with more than one year of menopause, or patients having undergone bilateral oophorectomy.
- For premenopausal group: patients with regular menses during recent 3 months and having never received luteinizing hormone-releasing hormone (LHRH) analogue therapy.
- Patients who meet the above criteria can be enrolled whether they have received anti-cancer treatment or not.
Exclusion
- patients less than 60 years old who are amenorrhoeic but have not received bilateral oophorectomy or medical castration.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
1183 Patients enrolled
Trial Details
Trial ID
NCT02263846
Start Date
November 1 2011
End Date
July 1 2013
Last Update
April 13 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.